Literature DB >> 16449308

Obstetric and perinatal outcome and preliminary results of development of children born after in vitro maturation of oocytes.

Viveca Söderström-Anttila1, Teija Salokorpi, Miia Pihlaja, Silve Serenius-Sirve, Anne-Maria Suikkari.   

Abstract

BACKGROUND: Careful follow-up of children born after in vitro maturation (IVM) of human oocytes is essential because the technique is still very new.
METHODS: Obstetric and perinatal data were collected from all deliveries after IVM treatment during 1999-2004. The growth and development of IVM children was assessed at 6, 12 and 24 months using Muenchener Funktionelle Entwicklungs Diagnostik and Bayley Scales of Infants.
RESULTS: In total, 43 women [age 31.2 +/- 3.9 (mean +/- SD) years] gave birth to 40 singleton infants and three sets of twins (multiple rate 7.0%). Obstetric complications occurred in 15 pregnancies (35%). The mean birthweight of singleton infants was 3550 +/- 441 g and that of twins 2622 +/- 194 g. The rate of preterm birth infants was 5% in singletons. No perinatal deaths occurred. At the age of 12 months, eight children (19%) expressed minor developmental problems and one girl was found to have optical glioma. At 2 years of age, neuropsychological development was within the normal range.
CONCLUSIONS: The obstetric and perinatal outcome was good, and the mean birthweight of the infants was normal. Minor developmental delay was overexpressed at 12 months, but the development of the children was normal at 2 years.

Entities:  

Mesh:

Year:  2006        PMID: 16449308     DOI: 10.1093/humrep/dei503

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  22 in total

Review 1.  Intracytoplasmic sperm injection (ICSI)--what are the risks?

Authors:  Joseph P Alukal; Dolores J Lamb
Journal:  Urol Clin North Am       Date:  2008-05       Impact factor: 2.241

2.  Health of IVM children.

Authors:  Emre Basatemur; Alastair Sutcliffe
Journal:  J Assist Reprod Genet       Date:  2011-04-07       Impact factor: 3.412

Review 3.  Applicability of adult techniques for ovarian preservation to childhood cancer patients.

Authors:  Laura Detti; Daniel C Martin; Lucy J Williams
Journal:  J Assist Reprod Genet       Date:  2012-07-21       Impact factor: 3.412

4.  Oocyte cryopreservation for women with GATA2 deficiency.

Authors:  Jessica R Zolton; Toral P Parikh; Dennis D Hickstein; Steven M Holland; Micah J Hill; Alan H DeCherney; Erin F Wolff
Journal:  J Assist Reprod Genet       Date:  2018-03-13       Impact factor: 3.412

5.  Oncofertility in Canada: cryopreservation and alternative options for future parenthood.

Authors:  R Ronn; H E G Holzer
Journal:  Curr Oncol       Date:  2014-02       Impact factor: 3.677

6.  In vitro maturation (IVM) of oocytes recovered from ovariectomy specimens in the laboratory: a promising "ex vivo" method of oocyte cryopreservation resulting in the first report of an ongoing pregnancy in Europe.

Authors:  Ingrid Segers; Ileana Mateizel; Ellen Van Moer; Johan Smitz; Herman Tournaye; Greta Verheyen; Michel De Vos
Journal:  J Assist Reprod Genet       Date:  2015-08-08       Impact factor: 3.412

7.  Effect of in vitro maturation of mouse oocytes on the health and lifespan of adult offspring.

Authors:  J J Eppig; M J O'Brien; K Wigglesworth; A Nicholson; W Zhang; B A King
Journal:  Hum Reprod       Date:  2009-01-16       Impact factor: 6.918

8.  Comparison of developmental status of 5-year-old singleton children born through assisted and natural conceptions.

Authors:  Razieh Fallah; Sedighah Akhavan Karbasi; Mohammad Taghi Galalian; Razieh Dehghani-Firouzabadi
Journal:  Iran J Reprod Med       Date:  2013-05

Review 9.  Perspectives on the development and future of oocyte IVM in clinical practice.

Authors:  Michel De Vos; Michaël Grynberg; Tuong M Ho; Ye Yuan; David F Albertini; Robert B Gilchrist
Journal:  J Assist Reprod Genet       Date:  2021-07-03       Impact factor: 3.412

10.  Growth development of French children born after in vitro maturation.

Authors:  Laurence Foix-L'Hélias; Michael Grynberg; Béatrice Ducot; Nelly Frydman; Violaine Kerbrat; Jean Bouyer; Philippe Labrune
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.